APA (7th ed.) Citation

LR, V., EC, W., NE, C., MR, M., T, Z., PM, L., & RA, V. (2025). The cytosolic branched-chain amino transferase 1 (BCAT1/BCATc) inhibitor reduces mitochondrial capacity in a myotube model of insulin resistance. Journal of endocrinological investigation, 48(10), 2489. https://doi.org/10.1007/s40618-025-02641-1

Chicago Style (17th ed.) Citation

LR, VanDerStad, Wyatt EC, Cook NE, McGovern MR, Zaman T, Lundin PM, and Vaughan RA. "The Cytosolic Branched-chain Amino Transferase 1 (BCAT1/BCATc) Inhibitor Reduces Mitochondrial Capacity in a Myotube Model of Insulin Resistance." Journal of Endocrinological Investigation 48, no. 10 (2025): 2489. https://doi.org/10.1007/s40618-025-02641-1.

MLA (9th ed.) Citation

LR, VanDerStad, et al. "The Cytosolic Branched-chain Amino Transferase 1 (BCAT1/BCATc) Inhibitor Reduces Mitochondrial Capacity in a Myotube Model of Insulin Resistance." Journal of Endocrinological Investigation, vol. 48, no. 10, 2025, p. 2489, https://doi.org/10.1007/s40618-025-02641-1.